BL
AGN

Balentine LLC’s Allergan plc AGN Stock Holding History

Balentine LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-299
Closed -$53K – 966
2020
Q1 		$53K Buy
299
+31
+12% +$5.84K ﹤0.01% 175
2019
Q4 		$51K Buy
268
+182
+212% +$32.8K ﹤0.01% 187
2019
Q3 		$14K Buy
86
+36
+72% +$5.87K ﹤0.01% 294
2019
Q2 		$8K Buy
50
+8
+19% +$1.11K ﹤0.01% 381
2019
Q1 		$6K Hold
42
– – ﹤0.01% 403
2018
Q4 		$6K Buy
42
+9
+27% +$1.48K ﹤0.01% 386
2018
Q3 		$6K Buy
+33
New +$6.06K ﹤0.01% 335
2018
Q1 		– Sell
-975
Closed -$159K – 589
2017
Q4 		$159K Sell
975
-68
-7% -$12.2K 0.01% 148
2017
Q3 		$214K Buy
1,043
+77
+8% +$17.9K 0.02% 113
2017
Q2 		$235K Buy
966
+51
+6% +$12K 0.02% 99
2017
Q1 		$219K Buy
915
+75
+9% +$17.5K 0.02% 100
2016
Q4 		$176K Sell
840
-1,374
-62% -$285K 0.02% 105
2016
Q3 		$510K Buy
2,214
+508
+30% +$124K 0.07% 37
2016
Q2 		$394K Buy
1,706
+7
+0.4% +$1.61K 0.08% 35
2016
Q1 		$455K Sell
1,699
-13
-0.8% -$3.72K 0.12% 29
2015
Q4 		$535K Sell
1,712
-201
-11% -$59.8K 0.11% 29
2015
Q3 		$520K Buy
1,913
+1,630
+576% +$501K 0.1% 26
2015
Q2 		$86K Sell
283
-38
-12% -$11.3K 0.01% 104
2015
Q1 		$96K Buy
+321
New +$91.5K 0.02% 95

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Balentine LLC's AGN Position: Q2 2020 in Review

Balentine LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 299 shares — an estimated $53K sold.

Balentine LLC first reported a position in AGN in Q1 2015 and held it in 19 quarters. The position peaked at $535K in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Balentine LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Balentine LLC sold 299 Allergan plc shares in Q2 2020, an estimated $53K.
  • Balentine LLC first reported a position in Allergan plc in Q1 2015 and held it in 19 quarters.
  • Balentine LLC's Allergan plc position peaked at $535K in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Balentine LLC's 13F filing for Q2 2020, filed 14 Aug 2020.